What this study is
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.
Study details
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Conditions
- Vascular Anomaly · Generalized Lymphatic Anomaly · Kaposiform Hemangioendothelioma · Kaposiform Lymphangiomatosis · Gorham-Stout Disease · Klippel Trenaunay Syndrome · Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
- Enrolling
- 1,000 people
- Starts
- 2015-04
- Est. completion
- 2050-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 1 Day and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented.
- All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
1 openCincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
- Megan Metcalf · Contact513-803-2606hvmcresearch@cchmc.org
- Timothy LeCras, PhD · Contact
- Adrienne Hammill, MD, PhD · Contact
RecruitingBoston Children's Hospital
Boston, Massachusetts, United States
Terminated
Study team
Sponsor
Children's Hospital Medical Center, Cincinnati
Study ID CCHMC-LMI
Principal investigator
Timothy LeCras, PhD
Children's Hospital Medical Center, Cincinnati
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.